Company / Free Cash Flow
Phathom Pharmaceuticals, Inc. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$167.0M
FY2025
5-year range
-$167.0M / -$139.2M
FY2021-FY2025
Trend
-20.0%
vs FY2024
Sector context
#137 of 194
Health Care
What the data says
At -$167M, Phathom Pharmaceuticals, Inc.'s free cash flow ranks #137 of 194 in the Health Care sector. Declined from -$139M to -$167M over the past 2 years.
Based on SEC 10-K filings.
-$167M in FY2025.
Declined from -$139M to -$167M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#137 of 194 in Health CareTop 71% of 194This company -$167.0M Sector average $470.8M
▼
-135.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 20.0% year-over-year.
- Ranks #137 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$167.0M | -20.0% |
| FY2024 | -$139.2M | +0.0% |
| FY2023 | -$139.2M | +5.7% |
| FY2022 | -$147.6M | +0.8% |
| FY2021 | -$148.8M | -110.4% |
| FY2020 | -$70.7M | -93.0% |
| FY2019 | -$36.6M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026